Gain Therapeutics SA has been selected to present on March 26th, 2019.
Gain Therapeutics SA
announces that it has received funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA to advance its proprietary non-competitive pharmacological chaperones for Parkinson’s disease.
Wednesday, February 28
​
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics
GLB1
Acid beta-galactosidase
GM1 ganglioside & keratan sulfate
Alpha-synuclein
1 : 100-200,000
No available treatment or cure
Preclinical
Lead Optimization